KYNTRA BIO, INC. (KYNB) Free cash flow 2016–2025
KYNTRA BIO, INC. (KYNB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.8MFY2025 · since FY2016: $5.9M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | +96.5% |
| FY2024 | -$138.3M | +56.5% |
| FY2023 | -$317.5M | -112.2% |
| FY2022 | -$149.7M | -71.2% |
| FY2021 | -$87.4M | -212.6% |
| FY2020 | $77.6M | +191.9% |
| FY2019 | -$84.5M | -0.4% |
| FY2018 | -$84.2M | -12.2% |
| FY2017 | -$75.0M | -1381.0% |
| FY2016 | $5.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross profitKYNB Gross marginKYNB Operating incomeKYNB Operating marginKYNB Operating cash flowKYNB Capital expendituresKYNB Return on equityKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →